MedTrace Logo

SPHERE Hypertension Intervention Study

NCT00495833 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8000

Last updated 2010-06-29

No results posted yet for this study

Summary

Overview: This study uses communications strategies delivered through the traditional emergency medical response system to increase the proportion of low-income adults who obtain blood pressure screening and follow-up information for hypertension treatment options. The project will test the effectiveness of source personalization and tailored messaging in motivating potentially high-risk people, identified by 911 responders, to come to a local fire station for hypertension screening.

Specific Aims: The specific aims are:

1. Test the effectiveness of three health marketing approaches to motivate high-risk people, identified via 911 responders, to come to a local fire station for hypertension screening. The mailed marketing approaches vary personalized risk information and personalization of source.
2. Test the effectiveness of two mailing interventions (blood pressure kits with and without promotional gifts) to increase blood pressure monitoring among patients who have come to a fire station for a second blood pressure check.

Conditions

Interventions

BEHAVIORAL

Personalized brochure

either photo personalization, blood pressure personalization, both, or no personalization

BEHAVIORAL

Promotional gift

half of participants who go to a fire station will receive a gift card.

Sponsors & Collaborators

Principal Investigators

  • Hendrika Meischke, PhD · University of Washington

  • Mickey Eisenberg, MD · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00495833 on ClinicalTrials.gov